Blue Cross and BCN will continue covering GLP-1s prescribed to treat Type 2 diabetes, including the medications Ozempic, Mounjaro, Rybelsus and Victoza
With this unmatched coverage, pharmaceutical manufacturers and healthcare researchers can move beyond traditional claims analysis to access verified insights that illuminate real-world treatment dynamics across diverse patient populations
For others, it may be simply an expense that doesnt meaningfully improve health or financial outcomes
Resistance training, may increase your resting metabolic rate
Watch for increased thirst and maintain hydration, as improved cellular metabolism may increase fluid requirements while GLP-1 suppresses appetite-driven fluid intake
Voc sabe o que eles so e qual a diferena entre eles